Evaluation of the Effectiveness of a Xospata Routine Risk Minimisation Measure (RMM) and an Additional Risk Minimisation Measure (aRMM): A Cross-sectional Survey Study among Healthcare Professionals to Assess Awareness and Knowledge First published 02/07/2021 Last updated 02/07/2024 EU PAS number:EUPAS37354 Study Finalised